Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Phenobarbital
Drug ID BADD_D01752
Description A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
Indications and Usage For the treatment of all types of seizures except absence seizures.
Marketing Status Not Available
ATC Code N03AA02
DrugBank ID DB01174
KEGG ID D00506
MeSH ID D010634
PubChem ID 4763
TTD Drug ID D0Y7RW
NDC Product Code 58118-0626; 16571-673; 69336-115; 75826-136; 71205-889; 0143-1495; 17856-0502; 66064-2001; 63629-2404; 16571-668; 63629-2289; 70752-167; 0603-5166; 70518-0822; 69367-212; 76003-0894; 16571-669; 51927-1015; 67296-1427; 0603-5165; 70518-2612; 51293-626; 16571-674; 69367-214; 63629-2043; 70752-162; 63629-2049; 63739-294; 58118-1110; 16571-675; 69367-213; 64380-166; 71205-892; 70752-168; 63739-192; 13517-111; 63629-2045; 70752-161; 65319-1450; 0143-1458; 0603-5167; 63629-2044; 13517-110; 51293-627; 63629-2402; 51293-693; 75826-143; 38779-0852; 51293-694; 63187-895; 63629-2047; 51293-692; 43063-953; 70752-165; 70518-0722; 70752-164; 70752-166; 17856-0174; 63629-2046; 51293-625; 69367-211; 70518-2418; 63629-2401; 71205-891; 59348-0011; 63629-2041; 13517-758; 70166-536; 71205-890; 13517-756; 69336-116; 60687-448; 69336-117; 13517-113; 13517-112; 0121-0531; 63629-2400; 0143-1455; 63629-2403; 70518-2407; 58624-0520; 70166-537; 16571-667; 0603-5168; 75826-142; 0904-6575; 63629-2291; 61919-109; 75826-141; 70752-163; 63629-2399; 63629-2042; 70518-2405; 13517-755; 16571-671; 63629-2290; 0143-1500; 75826-139; 75826-138; 69367-172; 51552-0745; 16571-672; 13517-757; 51293-691; 16571-670; 63629-2048; 63629-1033; 13517-107; 69336-118; 51293-628; 49452-5190; 0395-8090; 71205-893; 54932-207; 75826-137; 0603-1508; 54932-501; 63629-1032; 75826-140; 70752-157
Synonyms Phenobarbital | Phenylbarbital | Phenylethylbarbituric Acid | Acid, Phenylethylbarbituric | Phenemal | Phenobarbitone | Hysteps | Phenobarbital Sodium | Sodium, Phenobarbital | Phenobarbital, Monosodium Salt | Monosodium Salt Phenobarbital | Luminal | Gardenal
Chemical Information
Molecular Formula C12H12N2O3
CAS Registry Number 50-06-6
SMILES CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Toxicity to various agentsCytochrome P450 3A4P08684T37848Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperthermia12.05.01.002; 08.05.01.0010.001490%Not Available
Hypocalcaemia14.04.01.004--
Hypohidrosis23.02.03.005; 08.01.03.029--
Hypotension24.06.03.0020.002235%
Hypothermia12.05.03.001; 08.05.01.0030.001490%
Hypoventilation22.02.01.007--Not Available
Hypoxia22.02.02.003--
Injection site reaction08.02.03.014; 12.07.03.015--
Insomnia19.02.01.002; 17.15.03.002--
Intraocular pressure increased13.07.04.002--Not Available
Irritability19.04.02.013; 08.01.03.011--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.0040.002235%Not Available
Lactic acidosis14.01.01.0020.001490%Not Available
Laryngospasm22.04.02.002--
Lethargy08.01.01.008; 19.04.04.004; 17.02.04.0030.002980%
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.005--Not Available
Local swelling08.01.03.013--Not Available
Loss of consciousness17.02.04.004--Not Available
Meningitis bacterial17.06.10.002; 11.02.01.0130.001555%Not Available
Mental disability26.01.01.001--Not Available
Metabolic acidosis14.01.01.0030.001490%Not Available
Mood swings19.04.03.001--Not Available
Musculoskeletal pain15.03.04.007--
Myalgia15.05.02.001--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Myocarditis02.04.03.0010.001490%
Nausea07.01.07.001--
Necrosis24.04.02.006; 08.03.03.001--Not Available
Nervousness19.06.02.003--Not Available
Nightmare19.02.03.003--Not Available
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages